Extended-spectrum beta-lactamases (ESBLs) are one of the most common defence
mechanisms of gram-negative bacteria against beta-lactam antibiotics. Treatment options for …

Extended spectrum β-lactamase (ESBL)-producing organisms pose unique challenges to
clinical microbiologists, clinicians, infection control professionals and antibacterial-discovery …

Extended-spectrum β-lactamase (ESBL)-producing organisms are a global problem. No
randomized controlled trials have ever been performed to guide optimal treatment. However …

Introduction: The spread of extended-spectrum β–lactamase (ESBL)-producing
Enterobacteriaceae has become a major public health threat worldwide. Area covered: A …

Extended-Spectrum ß-Lactamase-Producing Enterobacteriaceae : Antibiotic consumption,
Detection and Resistance Epidemiology diva-portal.org Digitala Vetenskapliga Arkivet Simple …

Enterobacteriaceae, especially Klebsiella spp. producing extended-spectrum β-lactamases
(ESBLs) such as SHV and TEM types, have been established since the 1980s as a major …

Since first reported in Europe in the early 1980s, extended-spectrum β-lactamases (ESBLs)
have spread worldwide. When producing these broad-spectrum plasmid-encoded enzymes …

Extended-spectrum β-lactamase (ESBL) producing gram-negative bacilli are a growing
concern in human medicine today. When producing these enzymes, organisms (mostly K …

Extended-spectrum β-lactamases (ESBLs) are a group of plasmid-mediated, diverse,
complex and rapidly evolving enzymes that are posing a major therapeutic challenge today …

The Enterobacteriaceae, most notably Escherichia coli and Klebsiella pneumoniae, are
among the most important causes of serious nosocomial and community-acquired bacterial …